论文部分内容阅读
肝动脉栓塞化疗(TACE)是治疗不能手术切除的肝癌的首选方法。其疗效判定常常依靠AFP、B超、CT、血管造影。但约30％的原发性肝癌(PHC)AFP不高,B超有时不能区别坏死与肿瘤部的界限,CT和血管造影也较昂贵,不可能反复多次检查。有报道,血清甲状腺激素水平与肝癌病情及判断预后有关。本文旨在观察TACE治疗前后的血清甲状腺激素的变化,探讨血清甲状腺激素水平变化在TACE治疗后的临床意义。
Transcatheter arterial chemoembolization (TACE) is the preferred method for treating unresectable liver cancer. The efficacy determination often depends on AFP, B-ultrasonography, CT, and angiography. However, about 30% of primary liver cancer (PHC) AFP is not high, B-scan sometimes can not distinguish the boundaries of necrosis and tumor, CT and angiography are also more expensive, it is impossible to repeatedly check. It has been reported that serum thyroid hormone levels are related to liver cancer condition and prognosis. This article aims to observe the changes of serum thyroid hormone before and after TACE treatment, to explore the clinical significance of serum thyroid hormone levels after TACE treatment.